Product
TNX-102 SL
2 clinical trials
5 indications
Indication
FibromyalgiaIndication
COVID-19Indication
Long COVIDIndication
Long Haul COVIDClinical trial
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of TNX-102 SL Taken Daily At Bedtime In Patients With FibromyalgiaStatus: Completed, Estimated PCD: 2023-11-14
Clinical trial
A Phase 2, 14-week Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Multisite Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)Status: Completed, Estimated PCD: 2023-07-12